Jun Feng
92Patents
18h-index
120Co-inventors
87Inventor score
Filing activity: Dec 23, 1998 → Feb 14, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9840516B2 | Substituted quinazolines as inhibitors of KRAS G12C | Chemistry; Metallurgy | 64 | Active |
| US6613942B1 | Glucagon antagonists/inverse agonists | Chemistry; Metallurgy | 45 | Expired |
| US9227978B2 | Covalent inhibitors of Kras G12C | Physics | 45 | Active |
| US9745319B2 | Irreversible covalent inhibitors of the GTPase K-Ras G12C | Chemistry; Metallurgy | 44 | Active |
| US9862701B2 | Inhibitors of KRAS G12C mutant proteins | Chemistry; Metallurgy | 39 | Active |
| US9926267B2 | Covalent inhibitors of K-Ras G12C | Physics | 37 | Active |
| US10144724B2 | Substituted quinazoline compounds and methods of use thereof | Physics | 36 | Active |
| US10414757B2 | 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof | Chemistry; Metallurgy | 30 | Active |
| US10370386B2 | Substituted quinolines as inhibitors of KRAS G12C | Chemistry; Metallurgy | 29 | Active |
| US10377743B2 | Inhibitors of RAS and methods of use thereof | Chemistry; Metallurgy | 29 | Active |
| US10351550B2 | Substituted quinazoline compounds and methods of use thereof | Physics | 27 | Active |
| US10246424B2 | Substituted quinazoline compounds and methods of use thereof | Chemistry; Metallurgy | 27 | Active |
| US10428064B2 | Fused-tricyclic inhibitors of KRAS and methods of use thereof | Chemistry; Metallurgy | 27 | Active |
| US10736897B2 | Compounds and methods of use thereof for treatment of cancer | Chemistry; Metallurgy | 26 | Active |
| US10280172B2 | Inhibitors of KRAS G12C mutant proteins | Chemistry; Metallurgy | 26 | Active |
| US10273207B2 | Covalent inhibitors of kras G12C | Physics | 24 | Active |
| US9434743B2 | Indazole derivatives | Chemistry; Metallurgy | 19 | Active |
| US7550590B2 | Dipeptidyl peptidase inhibitors | Chemistry; Metallurgy | 19 | Expired |
| US10647703B2 | Inhibitors of KRAS G12C mutant proteins | Chemistry; Metallurgy | 18 | Active |
| US8871774B2 | Inhibitors of influenza viruses replication | Human Necessities | 17 | Active |
| US10745385B2 | Covalent inhibitors of KRAS | Chemistry; Metallurgy | 16 | Active |
| US10689356B2 | Inhibitors of KRAS G12C mutant proteins | Chemistry; Metallurgy | 16 | Active |
| US7781584B2 | Dipeptidyl peptidase inhibitors | Chemistry; Metallurgy | 15 | Active |
| US10730867B2 | Inhibitors of KRAS G12C mutant proteins | Human Necessities | 15 | Active |
| US10723738B2 | Inhibitors of KRAS G12C mutant proteins | Chemistry; Metallurgy | 15 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.